Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTION2: Indobufen vs Aspirin in Elderly ACS Patients After DES Implantation
NCT06451198Phase 4Recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- May 2025
- Primary completion
- Dec 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of Indobufen in acute coronary syndrome (ACS), sponsored by Zhongshan Hospital, Fudan University. Started May 2025; status: recruiting.
02
Drugs
Indobufen
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT06451198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06451198.